MedCap president pleads guilty to huge private-placement fraud

MAY 13, 2012
It looks like jail time for a former principal of Medical Capital Holdings Inc., the firm behind the fraudulent private placements that destroyed dozens of broker-dealers and wiped out almost $1 billion in investor cash. Former Medical Capital president Joseph J. Lampariello last Monday pleaded guilty to wire fraud and faces up to 21 years in federal prison and an order to pay $49 million in restitution, according to a report in The Orange County Register. The press report stated that the plea agreement was filed under seal in U.S. District Court in the Central District of California. Calls placed last Tuesday to Mr. Lampariello's attorney, Amy Karlin, to confirm the report weren't returned. Assistant U.S. Attorney Jennifer Waier didn't return calls. Thomas Mrozek, a spokesman for the U.S. Attorney's Office in Los Angeles, declined to comment. Between 2003 and 2009, Medical Capital raised almost $2 billion by selling private notes, purportedly to buy discounted medical receivables such as unpaid doctor or hospital bills that the firm would collect at full price. A court-appointed receiver later charged that Medical Capital was a “Ponzi-like scheme” that resulted in about $1 billion in losses for 12,000 investors.

WIPED OUT

Dozens of independent broker-dealers sold MedCap notes. Many have since gone out of business due to massive costs from lawsuits by investors looking to regain money lost in the fraud. Medical Capital's former chief executive, Sidney Field, hasn't been criminally charged. Both Mr. Field and Mr. Lampariello, 58, were sued by the Securities and Exchange Commission in July 2009 for fraud in their running of Medical Capital's last offering, Medical Provider Funding Corp. VI, known as MedCap VI in the brokerage industry. That case was later closed in order for criminal proceedings to continue. According to the Justice Department's information filing against Mr. Lampariello last month, he defrauded the note holders of MedCap VI from August 2008 until June 2009. Investors were told that the proceeds raised by MedCap VI would be used to purchase account receivables, make loans, pay sales commissions and other costs, and provide funds for general operating purposes, according to the filing. In fact, Mr. Lampariello and others “misappropriated investor funds” in order to “make Ponzi-type payments to note holders from earlier” partnerships and to pay fees to Medical Capital. He caused MedCap VI note holders to lose about $39 million, according to the filing. Mr. Lampariello, according to a separate federal charge, “earned $6.2 million from MedCap from 2004 through 2008, including $1.47 million in 2008 alone, but failed to file federal tax returns. On Monday, he pleaded guilty to a single count of failing to file a tax return in 2008,” The Orange County Register reported. When the SEC took over, the company reportedly owned a medical nuclear reactor and two closed hospitals that had lost their operating licenses. MedCap also was reportedly involved in producing a feature-length movie about a Mexican Little League team. [email protected]

Latest News

IRA assets swell to $19.2 trillion as 401(k) rollovers drive growth
IRA assets swell to $19.2 trillion as 401(k) rollovers drive growth

IRAs now hold nearly twice the assets of 401(k) plans — and most of that money didn't arrive through annual contributions.

Women feel confident about saving, but many still keep cash in low-yield accounts
Women feel confident about saving, but many still keep cash in low-yield accounts

A new survey finds that many women prioritize financial security but continue to leave savings in accounts that may not keep pace with inflation.

SEC seeks comment on prediction-market ETFs after May pause
SEC seeks comment on prediction-market ETFs after May pause

Roundhill, Bitwise and GraniteShares funds remain on hold while the agency weighs how novel ETFs should be regulated.

Dump investment banks, buy alternative asset managers, says Oppenheimer
Dump investment banks, buy alternative asset managers, says Oppenheimer

"Shares of alternative assets managers have lagged this year as investors grow wary of private-credit exposure."

TaxStatus rolls out rules-based tool to flag advice gaps
TaxStatus rolls out rules-based tool to flag advice gaps

The fintech platform is touting a new AI-free Planning Observations feature, which draws on IRS tax records to uncover opportunities for advisors.

SPONSORED Who builds the income when the pension disappears?

Dan Biagini of American Equity says the steady decline of pensions, longer lifespans and a reset in interest rates are rewriting how advisors build retirement income

SPONSORED Why direct indexing stopped being optional

Direct indexing is on pace to outgrow ETFs and mutual funds. Northern Trust's Ken Lassner explains why the advisors who get it wish they had started sooner.